Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells
暂无分享,去创建一个
N. Montserrat | J. Penninger | S. Boulant | M. Stanifer | A. Mirazimi | E. Garreta | V. Monteil | Patricia Prado | Astrid Hagelkruys | D. Moya-Rull | Gustav Jonsson | C. Tarantino | Maria Gallo | A. Marco | Daniel Moya-Rull
[1] F. Prósper,et al. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells , 2022, Cell Metabolism.
[2] Timothy A. Blenkinsop,et al. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium , 2021, Cell Stem Cell.
[3] Mingyao Li,et al. The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation. , 2020, Cell metabolism.
[4] Martin Stahl,et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.
[5] Dobryna Zalvidea,et al. Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells , 2019, Nature Materials.